Drawing for YPSOMATE

USPTO serial 79029767

YPSOMATE

Reviewed by CopyMark Law Group

Reg. 3302941Status 739Renewal
Filing date
Status date
Registration date
Oct 2, 2007
Examiner
WILLIAMS, IRENE
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with YPSOMATE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Medical and medicinal apparatus and instruments, namely, [ perfusion, inhalation, infusion and ] injection apparatus and accessories therefore, namely, needles [, catheters, lancets, bistouries and ampules; medical apparatus for diagnostic purposes, namely, blood glucose meters, body fluid analysers; glucose measuring strips ]ACTIVE—
042[Scientific and technological research services and work as well as designer services related thereto; industrial analysis and research services; technical project study; design and development of medical and medicinal apparatus and instruments as well as computer equipment and software in connection with medical and medicinal apparatus and instruments, in particular administration apparatus consisting of perfusion, inhalation and injection apparatus and their accessories, needles, bistouries and ampules]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 2, 2026REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Sep 3, 2026RNWLINTERNATIONAL REGISTRATION RENEWED—
Jan 8, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 20, 2020CHLDCHANGE OF OWNER RECEIVED FROM IB—
Mar 27, 2018NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Mar 27, 2018C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Mar 27, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 9, 2018ES75TEAS SECTION 71 & 15 RECEIVED—
Oct 2, 2016REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Oct 1, 2016RNWLINTERNATIONAL REGISTRATION RENEWED—
May 12, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 12, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 22, 2015INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Sep 7, 2015INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 31, 2015INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jan 7, 2015XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jan 7, 2015XXCRGENERIC MADRID TRANSACTION CREATED—
Jun 9, 2014INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 9, 2013NA71NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED—
Oct 9, 201371.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Oct 9, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 4, 201371AFREGISTERED-SEC.71 FILED—
Oct 4, 2013ES71TEAS SECTION 71 RECEIVED—
Dec 14, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 18, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 18, 2008FIMPFINAL DISPOSITION PROCESSED—
Jan 9, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 2, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 17, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 27, 2007NPUBNOTICE OF PUBLICATION—
Jun 14, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 14, 2007CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 14, 2007ALIEASSIGNED TO LIE—
May 19, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 19, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 18, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 18, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 17, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 17, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 17, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 8, 2006RFNTREFUSAL PROCESSED BY IB—
Nov 22, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 22, 2006RFRRREFUSAL PROCESSED BY MPU—
Nov 21, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 20, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 17, 2006DOCKASSIGNED TO EXAMINER—
Nov 14, 2006NWAPNEW APPLICATION ENTERED—
Nov 9, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance